CVE-2026-28356multipart is a fast multipart/form-data parser for python.
Updated under an hour ago ()
Does this affect you?
It lists no affected products yet. Add what you run and Signals checks it as products are added.
No exploitation reported and no EPSS estimate yet.
multipart is a fast multipart/form-data parser for python. Prior to 1.2.2, 1.3.1 and 1.4.0-dev, the parse_options_header() function in multipart.py uses a regular expression with an ambiguous alternation, which can cause exponential backtracking (ReDoS) when parsing maliciously crafted HTTP or multipart segment headers. This can be abused for denial of service (DoS) attacks against web applications using this library to parse request headers or multipart/form-data streams. The issue is fixed in 1.2.2, 1.3.1 and 1.4.0-dev.
- CVSS
- 7.5 HIGH (v3.1, NVD)CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
- Weakness (CWE)
- CWE-1333
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- Not given
- NVD analysis
- Deferred
- Record last updated
- Aug 24, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
No affected products are listed yet.
References
- https://github.com/defnull/multipart/security/advisories/GHSA-p2m9-wcp5-6qw3
- https://access.redhat.com/errata/RHSA-2026:10184
- https://access.redhat.com/errata/RHSA-2026:37275
- https://access.redhat.com/errata/RHSA-2026:42644
- https://access.redhat.com/errata/RHSA-2026:5809
- https://access.redhat.com/errata/RHSA-2026:6761
- https://access.redhat.com/errata/RHSA-2026:6762
- https://access.redhat.com/security/cve/CVE-2026-28356
- https://bugzilla.redhat.com/show_bug.cgi?id=2447059
- https://security.access.redhat.com/data/csaf/v2/vex/2026/cve-2026-28356.json
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.